Cochlear Limited
CHEOY | OTC
$49.30
-$0.96 (-1.91%)
Nov 2, 2026, 11:31 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 2.33B | 2.34B | 2.24B | 1.94B | 1.64B | 1.49B |
Cost of Revenue | 688M | 615.2M | 562.1M | 488M | 411M | 410.2M |
Gross Profit | 1.65B | 1.73B | 1.67B | 1.47B | 1.23B | 1.08B |
Operating Income | 301M | 406.1M | 521.5M | 389.5M | 361.7M | 327.9M |
Interest Income | 10.2M | 11.7M | 19M | 16.5M | 2.4M | 3.6M |
Pretax Income | 201M | 518.5M | 484.8M | 396.8M | 393.8M | 363.5M |
Net Income | 147.3M | 388.9M | 356.8M | 300.6M | 289.1M | 326.5M |
Selling & General & Admin | 1.02B | 939.9M | 897.6M | 810.4M | 657.7M | 560.2M |
Research & Development | 323.2M | 291.5M | 277M | 244.9M | 210.7M | 195M |
Other Expenses | n/a | 90.4M | 84.9M | 3.3M | 73M | 104.1M |
Operating Expenses | 1.35B | 1.32B | 1.26B | 1.06B | 941.4M | 855.4M |
Interest Expense | 13.2M | 11M | 9.2M | 9.4M | 8.6M | 12M |
Selling & Marketing Expenses | n/a | 732M | 685M | 606.5M | 498.7M | 444.1M |
Cost & Expenses | 2.03B | 1.94B | 1.82B | 1.62B | 1.35B | 1.27B |
Income Tax Expense | 53.7M | 129.6M | 128M | 96M | 104.7M | 38M |
Shares Outstanding (Basic) | 65.42M | 65.44M | 65.54M | 65.77M | 65.73M | 65.73M |
Shares Outstanding (Diluted) | 65.54M | 65.44M | 65.71M | 65.9M | 65.77M | 65.73M |
EPS (Basic) | 2.25 | 5.94 | 5.44 | 4.57 | 4.40 | 4.93 |
EPS (Diluted) | 2.25 | 5.94 | 5.43 | 4.56 | 4.40 | 4.93 |
EBITDA | 407M | 619.9M | 579.5M | 487.1M | 475.4M | 451.9M |
EBIT | 301M | 529.5M | 494M | 406M | 402.4M | 375.5M |
Depreciation & Amortization | 106M | 90.4M | 84.9M | 80.9M | 73M | 76.4M |
Add to Watchlist
Select watchlists to add or remove CHEOY